KRAS and colorectal carcinoma: Further investigation of 54 CRC specimens identified that FUBP1 was highly expressed in KRAS‐mutant CRC specimens (n = 14) compared with KRAS wild‐type specimens (n = 40; P < 0.001; Fig. 7A,B).